FDA Investigator Phung Thien Nguyen
Phung Thien Nguyen has conducted inspections on 49 sites in 1 countries as of 02 Nov 2010. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
49
Last Inspection Date:
02 Nov 2010
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Phung Thien Nguyen:
Adam J Taylor,
Aditi S Thakur,
Alan M Barker,
Alan M Roberts,
Alecia L Marson,
Alicia M Mozzachio,
Alois P Provost,
Amanda Dinaro,
Amanda S Zorn,
Ana E Morales,
Ana L Kewes,
Anastasia M Shields,
Andrew A Leboeuf,
Andrew J Barrowcliff,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony F Lorenzo,
Anthony M Criscuolo, Jr,
Antoinette L Chancey,
Ariel Cruz Figueroa,
Arsen Karapetyan,
Ashley L Reiber,
Barry Cherney, PhD,
Brian D Nicholson,
Brian P Emanuel,
Brittani N Franklin,
Brittany R Laymon,
Bruce H Mccullough,
Bryan L Mcguckin,
Burnell M Henry,
Carl A Huffman, III,
Carrie Ann Plucinski,
CDR Sean T Creighton,
Chad E Schmear,
Chad W Rice,
Charles L Zhou,
Charlie P Booker,
Chase S Baldwin,
Christina A Miller,
Christina V Santos,
Christopher D Leach,
Clotia Cabbey Mensah,
Constantin Y Philopoulos,
Daniel B Arrecis,
Daniel J Brown,
Dariusz Galezowski,
Darrell E Luedtke,
David J Gasparovich,
David Perkins,
Debra I Love,
Debra Lboyd Seale,
Denarvis C Mendenhall,
Denise L Burosh,
Denise M Digiulio,
Dr. Gang Wang, PhD,
Eboni S Funderburk,
Edwardstine J Reese,
Elizabeth L Philpy,
Emma R Schaefer,
Eric M Mueller, PharmD,
Eric S Pittman,
Gregory R Dill,
Howard Sklamberg,
Humera T Khan,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James L Finn,
James T Karpus,
James W Plucinski,
Janae D Price,
Jason F Chancey,
Jeanne J Thai,
Jeanne M Morris,
Jennifer A D'angelo,
Jennifer C Adams,
Jennifer C Johnson,
Jennifer L Mecher,
Jesse A Vazquez,
Joan A Loreng,
Jocelyn C Turner,
John A Iwen,
John M Seale,
Joseph A Morkunas,
Joseph A Piechocki,
Joseph D Cooper,
Joshua M Adams,
Justin A Boyd,
Karen Emasley Joseph,
Kathleen S Tormey,
Kristen D Jarell,
Kristen E Szenderski,
Kshitij A Patkar,
Kujtim Sadiku,
Kyran R Gibson,
Larry F Hallberg,
Latoya A Griffith,
Laurie A Haxel,
Lawrence J Stringer,
Lawrence R Terando,
Lee Terry Moore,
Lequita M Mayhew,
Leslie D Hintz,
Liliya V Bubiy,
Linda F Murphy,
Lisa C Lewis,
Lisa Hayka,
Lisa Hornback,
Lisa M Bellows,
Lisa M Feola,
Logan M Ebeling,
Lorelei S Jarrell,
Maksim A Levenchuk,
Marcia A Worley,
Margaret Torres Vazquez,
Maria Diaz,
Mark E Frank,
Mark G Peterson,
Mark I Kaspar,
Matthew J Sienko,
Michael D Robinson,
Michael R Giammanco,
Michele L Glendenning,
Michele Perry Williams,
Mihaly S Ligmond,
Min Chu Chen,
Nibin Varghese, MS,
Nicholas F Lyons,
Nicholas J Presto,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole J Clausen,
Nicole S Williams,
Norman L Brown,
Norman Wong,
Pablo Alcantara,
Paola S Barnett,
Patricia A Mcilroy,
Patrick C Klotzbuecher,
Patrick E Gainer,
Paula A Trost,
Paula P Demichael,
Peng Zhou,
Peyton B Greenwood,
Prabhu P Raju,
Rachel T Evans,
Rafael Padilla,
Ralph A Erickson,
Rebecca K Olin,
Rebecca Rodriguez,
Robert D Tollefsen,
Roberta W Cunningham,
Rona Leblanc, PhD,
Rose Ashley,
Rosemary Wood Sexton,
Roshni J Patel,
Ross J Grigsby,
Russ R Rivy,
Russell K Riley,
Ryan Gibson,
Ryan S Martin,
Samina S Khan,
Samuel W Labinjo,
Sandra A Boyd,
Sandra A Hughes,
Sarah E Rhoades,
Shafiq S Ahadi,
Shana L Williams,
Simone E Pitts,
Stefen D Mcmillan,
Stephanie A Wright,
Stephen C Mahoney,
Stephen D Eich,
Sudha Shukla,
Sullan,
Susan D Yuscius,
Susan P Bruederle,
Susan W Ciani,
Tamara Brey,
Tara C Alcazar,
That Q Dang,
Thomas J Arista,
Thomas L Bellonte,
Thunder N Dunkijacobs,
Timothy Brennan,
Todd M Stankewicz,
Veronica Fuentes, MS,
Wayne D Stowell,
William D Sherman,
William G Nelson,
William R Weissinger,
Yvonne E Lozano
Phung Thien Nguyen's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2010 | EIR | Rising Pharma Holdings, Inc. - EIR, 2010-09-17 |
| September, 2010 | FDA 483 | Rising Pharma Holdings, Inc. - Form 483, 2010-09-17 |
| August, 2009 | FDA 483 | Central Admixture Pharmacy Services Inc. - Form 483, 2009-08-12 |
| September, 2009 | FDA 483 | American Blending & Filling Company, Inc. - Form 483, 2009-09-22 |
| February, 2010 | FDA 483 | AbbVie Inc. - Form 483, 2010-02-01 |
| September, 2010 | FDA 483 | Rising Pharma Holdings, Inc. - Form 483, 2010-09-17 |
| February, 2010 | FDA 483 | Xttrium Laboratories, Inc. - Form 483, 2010-02-19 |
| September, 2010 | FDA 483 Response | Rising Pharma Holdings, Inc. - Form 483R, 2010-10-05 |
| November, 2010 | FDA 483 | Merix Pharmaceutical Corporation - Form 483, 2010-11-22 |
| March, 2009 | FDA 483 | Fresenius Kabi USA, LLC - Form 483, 2011-03-18 |
| May, 2009 | EIR | Baxter Healthcare Corporation - EIR, 2009-05-09 |
| February, 2009 | FDA 483 | Celgene Corp., d.b.a. Abraxis BioScience LLC - Form 483, 2009-02-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more